Keith S. Ehrlich serves as Executive at SYNTA PHARMACEUTICALS CORP, where they oversee executive responsibilities. Since joining the company, Keith S. Ehrlich has executed 7 insider transactions totaling $69.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 28, 2017 involved transacting 70,000 shares valued at $35.0K.
Keith S. Ehrlich currently holds 121,813 shares of SYNTA PHARMACEUTICALS CORP (SNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Keith S. Ehrlich has been a net seller of SNTA stock. They have purchased $0 and sold $69.3K worth of shares.
Keith S. Ehrlich's most recent insider trade was on Mar 28, 2017, when they sold 70,000 shares at $0.50 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 1, 2012 | SNTA | $20.7K | Sale | 4,397 | $4.70 | Discretionary |
| Mar 1, 2011 | SNTA | $14.0K | Sale | 2,537 | $5.51 | Discretionary |
| Mar 1, 2011 | SNTA | $0 | Award | 4,397 | $N/A | Discretionary |
| Mar 1, 2010 | SNTA | $0 | Award | 5,284 | $N/A | Discretionary |
| Jan 5, 2009 | SNTA | $34.6K | Sale | 5,600 | $6.18 | Discretionary |